Pilot Test of Caregiver Training Protocol for Brachial Plexus Birth Injury
Launched by HUGO W. MOSER RESEARCH INSTITUTE AT KENNEDY KRIEGER, INC. · Sep 30, 2024
Trial Information
Current as of July 06, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is looking at a new training program for caregivers of infants with Brachial Plexus Birth Injury (BPBI), which can lead to weakness or paralysis in one arm. The goal is to help caregivers learn how to do special stretching exercises, called passive range of motion (PROM), that can improve their child's arm movement and prevent stiffness. The study will compare the effectiveness of this new training method to standard training, focusing on whether it helps caregivers feel more confident and capable in performing these important exercises every day.
To participate, caregivers must be at least 18 years old and have a baby who is 6 months or younger with a confirmed diagnosis of BPBI. Those who join can expect to receive training on how to perform the stretching exercises and will be asked about their confidence and ability to follow through on the training. This trial is important because it aims to find better ways to support caregivers, which could lead to improved outcomes for babies with BPBI, such as less risk of developing arm stiffness and better overall arm function as they grow.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Caregiver, age 18+ of an infant age 6 months or younger with a confirmed BPBI determined by the brachial plexus clinic team at an infant's first visit
- Exclusion Criteria:
- • Caregiver of an infant older than 6 months of age scheduled at the brachial clinic Caregiver of an infant scheduled at the brachial plexus clinic with a diagnosis other than BPBI and/or co-morbidity known to cause joint contractures
- • Caregiver of infant with BPBI who requires surgery prior to nine months of age
- • Caregiver who does not speak English unless a JHMI interpreter is present at the clinic visit, at which point a short form consent will be used
About Hugo W. Moser Research Institute At Kennedy Krieger, Inc.
The Hugo W. Moser Research Institute at Kennedy Krieger, Inc. is a leading research institution dedicated to advancing the understanding and treatment of neurodevelopmental disorders. With a strong focus on innovative scientific research, the Institute fosters collaboration among experts in various fields, including neuroscience, genetics, and rehabilitation. By conducting rigorous clinical trials and studies, the Institute aims to translate findings into effective interventions that improve the quality of life for individuals with disabilities. Its commitment to excellence in research and patient care positions it as a pivotal player in the advancement of pediatric healthcare and therapeutic solutions.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Baltimore, Maryland, United States
St. Petersburg, Florida, United States
Patients applied
Trial Officials
Matthew Elrick, MD, PhD
Principal Investigator
Hugo W. Moser Research Institute at Kennedy Krieger, Inc.
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported